References
National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2008 [online]. Available from URL: http://www.nice.org.uk/media/B52/A7/TAMethodsGuideUpdatedJune2008.pdf [Accessed 2008 Aug 14]
Brazier J. Valuing health states for use in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 769–779
Claxton K. Exploring uncertainty in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 781–798
McCabe C, Claxton K, Culyer AJ. The NICE cost-effectiveness threshold: what it is and what that means. Pharmacoeconomics 2008; 26 (9): 733–744
Miners A. Estimating ‘costs’ for cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 745–751
Sculpher M. Subgroups and heterogeneity in cost-effectiveness analysis. Pharmacoeconomics 2008; 26 (9): 799–806
Sutton A, Ades AE, Cooper N, et al., on behalf of the NICE Decision Support Unit. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics 2008; 26 (9): 753–767
National Institute for Clinical Excellence. Guide to the methods of technology appraisal. London: NICE, 2004 [online]. Available from URL: http://www.nice.org.uk/niceMedia/pdf/TAP_Methods.pdf [Accessed 2008 Aug 14]
Earnshaw J, Lewis G. NICE guide to the methods of technology appraisal: pharmaceutical industry perspective. Pharmacoeconomics 2008; 26 (9): 725–727
Longworth L, Longson C. NICE methodology for technology appraisals: cutting edge or tried and trusted? Pharmacoeconomics 2008; 26 (9): 729–732
National Institute for Health and Clinical Excellence. Guide to the methods of technology appraisal: draft for consulation. London: NICE 2007
Hawthorne G, Richardson J, Day NA. A comparison of the assessment of quality of life (AQoL) with four other generic utility instruments. Ann Int Med 2001; 33: 358–370
National Institute for Health and Clinical Excellence. Guide to the single technology appraisal (STA) process. London: NICE 2006 [online]. Available from URL: http://www.nice.org.uk/niceMedia/pdf/staprocess.pdf [Accessed 2008 Aug 14]
Hutton J, Trueman P, Henshall C. Coverage with evidence development: an examination of conceptual and policy issues. Int J Technol Assess Health Care 2007; 23: 425–432
Tunis SR, Pearson SD. Coverage options for promising technologies: Medicare’s ‘coverage with evidence development’. Health Aff 2006; 25 (5): 1218–1230
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sculpher, M. NICE’s 2008 Methods Guide . Pharmacoeconomics 26, 721–724 (2008). https://doi.org/10.2165/00019053-200826090-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00019053-200826090-00001